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Genome-scale identification of cellular pathways
required for cell surface recognition
Sumana Sharma,1 S. Josefin Bartholdson,1,3 Amalie C.M. Couch,1 Kosuke Yusa,2
and Gavin J. Wright1
1Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom; 2Stem Cell Genetics
Laboratory, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom
Interactions mediated by cell surface receptors initiate important instructive signaling cues but can be difficult to detect in
biochemical assays because they are often highly transient and membrane-embedded receptors are difficult to solubilize
in their native conformation. Here, we address these biochemical challenges by using a genome-scale, cell-based genetic
screening approach using CRISPR gene knockout technology to identify cellular pathways required for specific cell surface
recognition events. By using high-affinity monoclonal antibodies and low-affinity ligands, we determined the necessary
screening parameters, including the importance of establishing binding contributions from the glycocalyx, that permitted
the unequivocal identification of genes encoding directly interacting membrane-embedded receptors with high statistical
confidence. Importantly, we show that this genome-wide screening approach additionally identified receptor-specific path-
ways that are required for functional display of receptors on the cell surface that included chaperones, enzymes that
add post-translational modifications, trafficking proteins, and transcription factors. Finally, we demonstrate the utility of
the approach by identifying IGF2R (insulin like growth factor 2 receptor) as a binding partner for the R2 subunit of
GABAB receptors. We show that this interaction is direct and is critically dependent on mannose-6-phosphate, providing
a mechanism for the internalization and regulation of GABAB receptor signaling. We conclude that this single approach
can reveal both the molecular nature and the genetic pathways required for functional cell surface display of receptors rec-
ognized by antibodies, secreted proteins, and membrane-embedded ligands without the need to make any prior assump-
tions regarding their biochemical properties.
[Supplemental material is available for this article.]
Membrane-compartmentalized cells receive instructional infor-
mation from their surroundings by extracellular signaling cues
that are often initiated by specific binding events made by plasma
membrane–embedded receptors. These extracellular interactions
are crucial for the normal development and function of multi-
cellular organisms and can be exploited therapeutically because
they are directly accessible to soluble drugs such as monoclonal
antibodies (mAbs) (Weiner 2015). Investigating extracellular cell
signaling interactions mediated by membrane receptor proteins
can be challenging because the proteins are amphipathic, making
them difficult to solubilize in their native conformation and
because the interactions are typified by weak interaction affinities;
consequently,most commonly usedmethods are generally unsuit-
able to detect this class of protein interactions (Wright 2009). The
biochemical features of low-affinity membrane receptor interac-
tions have necessitated the development of bespoke techniques
to detect them, and one approach involves expressing the entire
ectodomain of a receptor as a soluble recombinant protein. The
ectodomains are usually purposefully oligomerized so that they
can be used as highly avid probes to identify binding partners
by expression cloning or biochemical purifications (Wright et al.
2010). More recently, we and others have developed large-scale
systematic methods to identify novel receptor–ligand interactions
by screening for direct interactions within large protein libraries
containing hundreds of receptor ectodomains using ELISA (en-
zyme-linked immunosorbant assay)-style approaches (Bushell
et al. 2008; Ozkan et al. 2013; Visser et al. 2015). While successful,
this general approach has drawbacks that prevent its wider use by
most laboratories because compiling protein libraries containing
hundreds of proteins is resource intensive, and most researchers’
interests are usually focused on a single or small number of
proteins rather than the networks of interactions within receptor
protein families. Importantly, this technique requires that the
receptor binding function is retained when expressed by heterolo-
gous cells out of the context of the plasma membrane as a soluble
recombinant protein. While this is generally the case for proteins
that span the membrane once, this is more difficult for receptor
complexes and membrane proteins that span the membrane
multiple times, presenting additional challenges to characterize
their interactions. Moreover, methods detecting binding events
between recombinant proteins do not account for the complex
environment inwhich receptor interactionswouldnormally occur
at the cell surface, which includes contributions from a charged
glycocalyx of carbohydrates and lipids displayed on a dynamic
membrane.
The recent development of cell-based genetic screening ap-
proaches using highly efficient CRISPR methods now presents
the possibility to interrogate the genetic basis of cellular pheno-
types on a genome-wide scale (Koike-Yusa et al. 2014; Shalem3Present address: Department of Medicine, University of Cambridge,
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et al. 2014, 2015; Wang et al. 2014). Libraries of cells that contain
biallelic targeted loss-of-function alleles can be created, and by se-
lecting those cells with a phenotype of interest, the gene products
involved can be identified (Ma et al. 2015; Parnas et al. 2015;
Zhang et al. 2016). Here, we use genome-scale, cell-based CRISPR
knockout (KO) screens to determine the molecular basis of cell
surface recognition events made by mAbs, secreted proteins, and
receptors. We show that this technique is able to not only identify
genes encoding cell surface proteins that directly interact with
these binding probes but also reveal receptor-specific pathways re-
quired for receptor display at the cell surface in a functional form,
including enzymes required for essential post-translational modi-
fications, chaperones, and trafficking proteins.
Results
Genetic determinants of mAb cell surface epitope display
by genome-scale CRISPR screens
To determine if a genome-scale, cell-based CRISPR-KO approach
could identify genes that are required for specific cell surface
recognition events within the context of a plasma membrane,
we first selected a panel of six mAbs that brightly stained five
different cell surface receptors (Supplemental Table S1). To create
a population of mutant cells, the Cas9-expressing cells were trans-
duced at a low multiplicity of infection (∼0.3) with a library of
lentiviruses, each encoding a single gRNA from a pool of 90,709
individual gRNAs targeting 18,009 human genes (Tzelepis et al.
2016). Transduced cells that had lost the antibody epitope at the
cell surface were isolated by FACS, and the genes responsible for
this loss of binding were identified by comparing the relative
abundance of the different gene-specific gRNAs present in the sort-
ed cells compared with the total unsorted population using deep
sequencing of gRNA PCR products and enrichment analysis (Fig.
1A; Li et al. 2014). Initial experiments established that the day
of selection, the number of sorted cells, and sorting thresholds
influenced the success of the approach (see Methods), as well as
selecting high-activity clonal Cas9-expressing versions for each
cell line to homogenize and maximize the efficiency of genome
editing (Supplemental Fig. S1). By using this optimized approach,
gRNAs targeting the gene encoding the antibody receptor epitope
were specifically enriched in the sorted cells for each of the six an-
tibodies (false-discovery rate [FDR] <0.05) (see Supplemental Table
S1; Supplemental Data S1). In the case of selections using anti-
CD58, gRNAs targeting CD58 were the most highly enriched
(Fig. 1B). In cells selected with the anti-glycophorin A mAb, the
most enriched genes targeted GYPA encoding the receptor, as
well as genes required for sialylated O–linked glycan biosynthesis
(C1GALT1, C1GALT1C1, SLC35A1, CMAS)—which are presum-
ably critical for creating the extracellular antibody epitope—and
B
C
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Figure 1. A cell-based genome-scale CRISPR-KO approach identifies pathways required for monoclonal antibody surface epitope recognition.
(A) Schematic of the approach based on CRISPR/Cas9 technology using a genome-scale lentiviral gRNA library. Genes identified as being required for
surface display of the epitope recognized by an anti-CD58 (B) and anti-GYPA (C ) mAbs. The enrichment of gRNAs targeting each gene is quantified as
the robust rank aggregation (RRA) score calculated using the MAGeCK software between selected cells that had lost the mAb epitope versus control cells
and is shown plotted in rank order. (D) Genes identified as being required for surface display of the epitope recognized by an anti-CD59 mAb; here, genes
are ordered alphabetically for clarity. Circles represent individual genes and are sized according to their false-discovery rate (FDR): large circle = FDR<1%,
small circle = 1%<FDR<5%. Genes encoding the direct receptors are indicated with gray circles. Only genes with FDR<5% are named and are color-cod-
ed according to their function.
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the erythroid-specific transcription factor GATA1, which is likely
to be necessary for GYPA transcription in these cells (Fig. 1C).
Similarly, a mAb recognizing the glycosylphosphatidylinositol
(GPI)-anchored CD59 receptor identified not only CD59 as the
gene with the most enriched gRNAs but also 21 out of 27 enzymes
known to be required for GPI-anchor biosynthesis (Fig. 1D). In ad-
dition, a mAb recognizing the α2β1 integrin identified ITGB1 and
components of the Arp2/3 complex, demonstrating the epitope of
thismAb is located within the β1 and not α2 chain, and the critical
requirement of actin regulation, consistent with the known cell
biology of integrin function (Supplemental Table S1; Brakebusch
and Fassler 2003). A pathway analysis of all enriched genes that
were shared between antibody selection encoded proteins required
for protein secretion and glycosylation, as expected, but also iden-
tified housekeeping pathways such as ribosome biosynthesis and
RNAmetabolism (Supplemental Fig. S2).Weobserved that the rep-
resentation of these pathways was often reduced when selections
were performed several days later, suggesting these genes are re-
quired for long-term cell viability in culture and that antibody
staining was reduced on moribund cells. An independent repeat
of the selections using the anti-CD59 antibody again identified
CD59 as one of the most enriched genes together with genes in-
volved in the GPI-anchor biosynthesis pathway, showing that
the experimental parameters were tolerant of biological variation
(Supplemental Fig. S3; Supplemental Data S1). Together, these
data demonstrated that the genome-scale CRISPR-KO screening
approach could not only robustly identify the gene encoding the
antibody epitope for all of the six antibodies tested but also reveal
genes and pathways that are important in the cell biology for spe-
cific receptors.
CRISPR-KO screening identifies receptors and a role
for heparan sulfate in low-affinity interactions
While high-affinity mAbs are useful research tools and a few stud-
ies have previously shown the utility of CRISPR screens to identify
receptor-related cellular pathways (Parnas et al. 2015; Zotova et al.
2016; Burr et al. 2017), we next sought to determine if this ap-
proach could be used to identify low-affinity receptors for cell
signaling ligands. As a model system, we selected the interaction
between Plasmodium falciparum RH5 and its host receptor basigin
(BSG) because it is a low-affinity interaction (KD∼1 µM), is
biochemically and structurally well characterized and because
BSG was highly expressed on our Cas9-expressing HEK293 cell
line (Crosnier et al. 2011;Wright et al. 2014). To detect low-affinity
interactions, we increased binding avidity by clustering biotiny-
lated RH5 around a fluorescent streptavidin conjugate, and this
reagent bound to the surface of HEK293 cells as expected; howev-
er, precoating the cells with a blocking anti-BSG mAb did not
prevent all RH5 binding, suggesting there was an additional recep-
tor(s) for RH5 on HEK293 cells (Fig. 2A). This additional binding
was not due to a subfraction of inactive protein in the RH5
BA
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Figure 2. Identification of BSG and heparan sulfate as independent receptors for P. falciparum RH5 on HEK293 cells. (A) Biotinylated RH5 was clustered
around a streptavidin–PE conjugate and binding to HEK293 cells was analyzed by flow cytometry. RH5 binding is only partially reduced by a blocking anti-
BSG mAb relative to controls. (B) Rank-ordered genes identified from gRNA enrichment analysis required for cell surface display of an anti-BSG mAb (left)
and RH5 binding (right). Significantly enriched genes with a FDR<0.05 are colored (full screening results available in Supplemental Data S2); genes en-
coding the receptor (BSG) and chaperone (SLC16A1) were common to both screens, and a gene involved in GAG-biosynthesis (SLC35B2) was additionally
required for RH5 binding. (C) Binding of RH5 to cells is reduced when transduced with lentiviruses encoding gRNAs targeting either the receptor (BSG) or
enzymes required for HS synthesis (SLC35B2, EXTL3) relative to controls. Transduced polyclonal lines were used for this experiment. (D) RH5 binding to
SLC35B2-targeted HEK293 cells could be completely prevented if preincubated with a blocking anti-BSG mAb but not an isotype-matched control. (E)
RH5 binding to BSG-targeted HEK293 cells could be completely blocked if preincubated with 200 µg/mL heparin but not 200 µg/mL CS. A representative
of three independent (A and C) or technical (D and E) replicate experiments is shown.
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preparation since all binding could be prevented by heat treatment
(Supplemental Fig. S4A). To identify the receptor(s) for RH5 other
than BSG in this cellular context, we compared the genes required
for RH5 binding versus those necessary for surface expression of
BSG by using an anti-BSG mAb. The enriched gRNAs common
to both selections beyond those targeting general secretory path-
way genes corresponded to BSG, as expected, but also to a gene
encoding a monocarboxylate transporter, SLC16A1, which is a
known chaperone required for surface expression of BSG (Fig.
2B; Kirk et al. 2000). The most highly enriched gene in the cells
sorted using RH5 compared with anti-BSG was SLC35B2 (solute
carrier family 35 member B2), which encodes a protein that trans-
ports 3′-phosphoadenosine-5′-phosphosulfate from the cytosol
into the lumen of the Golgi apparatus, where sulfotransferases
use it as a universal donor for the sulfation of major constituents
of the cellular glycocalyx, including glycoproteins, glycolipids,
and glycosaminoglycans (GAGs) (Fig. 2B; Kamiyama et al. 2003).
An analysis of the enriched genes required for RH5 binding using
KEGG (Kanehisa et al. 2017) identified the heparan sulfate (HS)
biosynthesis pathway, and consistent with this, RH5 binding
could be inhibited to a threshold value by heparin, but not the re-
lated GAG, chondroitin sulfate (CS) (Supplemental Fig. S4B,C).
This is in agreementwith the reported presence of heparin binding
motifs in RH5 and its ability to bind heparin-coated agarose (Baum
et al. 2009). HS is a component of the cellular glycocalyx surround-
ing most cells and is known to adsorb a wide range of extracellular
proteins both as a coreceptor for signaling proteins and to interact
with the extracellular matrix (Esko et al.
2009). To further investigate the role of
SLC35B2 andHS in RH5 binding, we first
demonstrated that surface expression of
BSGwas not affected in cells where genes
required for GAG biosynthesis were tar-
geted (Supplemental Fig. S4D). We then
showed that cells targeted for genes re-
quired for HS biosynthesis (SLC35B2
and EXTL3) showed a partial reduction
in RH5 binding (Fig. 2C) and that the re-
sidual binding was specifically due to
BSG because it could be completely abro-
gated by preincubating the cells with the
blocking anti-BSG antibody (Fig. 2D).
This suggested that the contributions of
BSG and HS to RH5 binding were inde-
pendent, and this was further confirmed
by showing that soluble heparin, but not
CS, could block all RH5 binding to BSG-
deficient cells (Fig. 2E). These experi-
ments revealed a role for HS within the
glycocalyx for interactions at the cell
surface and demonstrated that this tech-
nique was able to identify the direct re-
ceptor of low-affinity ligands, including
any required receptor cofactors such as
chaperones.
Genome-scale, cell-based CRISPR-KO
screens identify directly interacting
receptors
Many extracellular proteins are known to
bindHS, and the finding that HS binding
in our assay could be additive rather than codependent on other
receptors suggested that HS may represent a factor responsible
for cell surface binding for a range of ligands even in the absence
of another receptor. To examine and address this, we took advan-
tage of our SLC35B2-targeted cell line to rapidly determine the
contribution of cell staining due to extracellular sulfate adsorption
by comparing ligand binding events between the parental and
SLC35B2-targeted cells. By using this approach, we identified six
ligands with known protein receptors, which, when presented as
avid binding reagents, bound HEK293 cells and exhibited no loss
of staining when SLC35B2 had been targeted. These ligands were
as follows: CRTAM, TIGIT, CD226, EPHB1, TNFRSF9, and N-termi-
nal receptor binding domain (RBD) of ERVW-1 (also known as
Syncytin 1) (Fig. 3A). When these protein probes were used in
our CRISPR screening approach, the gene with the most enriched
gRNAs corresponded to a known receptor in each and every case:
CADM1 was the top-ranked gene when selected with CRTAM,
PVR for both TIGIT and CD226 ligands, EFNB2 for EPHB1,
TNFSF9 for TNFRSF9, and SLC1A5 for the RBD of ERVW-1
(ERVW-1-RBD) (Fig. 3B). For TNFRSF9, several genes involved in
the p53 pathway (CDKN2A, CDC37, STK11, and DYRK1A) and
TP53 itself were also enriched in the nonbinding population, sug-
gesting a role for the p53 pathway in presenting TNFSF9 in a func-
tional ligand-binding formon the cell surface.Wevalidated this by
independently targeting TP53, which resulted in a decrease in the
binding of the TNFRSF9 ligand (Supplemental Fig. S5A). An inde-
pendent repeat of the selections using the TIGIT protein again
B
A
Figure 3. Identification of cell adhesion receptors and pathways using cell-based genetic screens.
(A) The indicated oligomeric probes were tested for binding to the unmodified parental cell line (red his-
tograms) or polyclonal SLC35B2-targeted cells (blue); representative experiments of three technical rep-
licates are shown. The HEK293 cell line was used for all proteins except TNFRSF9, which is the NCI-SNU-1
line. (B) RRA-score rank-ordered genes identified from gRNA enrichment analysis from sorted cells that
had lost binding to CRTAM, TIGIT, CD226, EPHB1, TNFRSF9, and ERVW-1 (ERVW-1-RBD); in all six cases,
the gene encoding the known receptor was identified as themost significantly enriched gene. In B, genes
with FDR <5% are labeled with colors corresponding to related functions (full screening results available
in Supplemental Data S3).
Genome-scale receptor pathway identification
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identified the gene encoding its receptor, PVR, as the most highly
enriched gene, demonstrating that the experimental parameters
were tolerant of biological variation (Supplemental Fig. S5B).
These experiments demonstrate that the directly interacting recep-
tor could be unambiguously identified with high statistical confi-
dence in every case, and for some proteins, the cellular pathways
responsible for the cell biology of the receptor can be determined.
IGF2R interacts with GABBR2 in a M6P-dependent manner
The results of these experiments suggested that the cell-based,
genome-scale CRISPR-KO approach could be used to identify
not only directly interacting cell surface receptors but also the cel-
lular pathways required for functional receptor presentation at the
cell surface. To demonstrate this, we identified the gamma-amino-
butyric acid (GABA) type B receptor subunit 2 (GABBR2) as a
receptor whose ectodomain bound HEK293 cells in an SLC35B2-
independent manner. GABBR2 has an important but mechanisti-
cally poorly understood role in the internalization of inhibitory
GABAB receptor complexes to regulate neurotransmission
(Hannan et al. 2011; Benke 2013). Sorted mutant cells that had
lost the ability to bind the GABBR2 ecto-
domain were enriched in gRNAs target-
ing the gene IGF2R (insulin like growth
factor 2 receptor, also known as the cat-
ion-independent mannose-6-phosphate
(M6P) receptor and CD222), as well as
several genes encoding proteins required
for endosomal trafficking and function
(Fig. 4A). These genes included subunits
of V-type ATPases (ATP6V0D1, ATP6AP1,
ATP6AP2, ATP6V1A, ATP6V1C1), a
chaperone required for V-ATPase assem-
bly (VMA21), V-ATPase assembly factors
(TMEM199, CCDC115), an accessory
factor involved in endosomal acidifica-
tion (WDR7), and proteins required for
membrane trafficking (VPS16, VPS18)
and fusion (VPS39). IGF2R is a known
cargo receptor that transports M6P-
modified proteins between the trans-
Golgi network, endosomes, and plasma
membrane and might therefore provide
a mechanism for the known internaliza-
tion and degradation of GABAB receptors
through interactions with the GABBR2
subunit (Grampp et al. 2007). To investi-
gate this further, we first showed using
immunocytochemistry that both pro-
teins were localized within the membra-
nous compartments of cells with IGF2R
localizing as discrete puncta in internal
membranes that also contained GABAB
receptors (Supplemental Fig. S6A). To
further investigate the interaction be-
tween these two proteins,we first validat-
ed our results using individual gRNAs
targeting IGF2R, which resulted in the
loss of both IGF2R surface staining (Sup-
plemental Fig. S6B) and binding of
the GABBR2 ectodomain (Fig. 4B). It is
known that cells treated with com-
pounds that increase lysosomal pH cause IGF2R to accumulate in
endosomes with a consequent loss from the cell surface, providing
an explanation for why genes required for endosomal function
and trafficking were also enriched (Reaves and Banting 1994).
Consistent with this, individual gRNAs targeting the WDR7
gene, which is required for lysosomal acidification (Merkulova
et al. 2015), resulted in the reduction of both IGF2R mAb staining
(Supplemental Fig. S6B) and GABBR2 ectodomain binding (Fig.
4B). To demonstrate that the loss of GABBR2 binding to cells
was due to the direct interaction with IGF2R, we first showed
that GABBR2 ectodomain binding could be conferred to cells
by transfecting them with an expression plasmid encoding
an IGF2R-GFP fusion protein (Supplemental Fig. S6C) and then
observed that the entire ectodomains of IGF2R expressed as a
soluble beta-lactamase–tagged “prey” could be specifically cap-
tured by a biotinylated GABBR2 ectodomain “bait” (Fig. 4C). We
further demonstrated that the interaction between IGF2R and
GABBR2 was dependent on M6P-modified N-linked glycans by
showing the interaction was abolished by either treating the
GABBR2 ectodomain with PNGase F (Supplemental Fig. S6D) or
adding soluble M6P (Fig. 4D). These results demonstrate that the
A C
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Figure 4. IGF2R interacts with GABBR2 in a mannose-6-phosphate (M6P)–dependent manner.
(A) RRA-score rank-ordered genes identified from gRNA enrichment analysis from sorted mutant cells
that had lost GABBR2 binding activity. Enriched genes encoded the IGF2R receptor and proteins involved
in lysosome biology (also see Supplemental Data S3). (B) Binding of GABBR2 was quantified on HEK293
cells transduced with two gRNAs targeting different exons of IGF2R and one gRNA targeting WDR7. A
near complete loss of binding was observed on IGF2R-targeted cells and a partial loss onWDR7-targeted
cells; targeted cells were maintained as polyclonal lines. A representative experiment of three technical
replicates is shown. (C) Direct binding between IGF2R and GABBR2 ectodomains. The biotinylated ecto-
domain of GABBR2 was immobilized as a “bait” on streptavidin-coated microtiter plates and tested for
direct interactions using a beta-lactamase–tagged “prey” ectodomain of IGF2R. Binding was quantified
using the beta-lactamase substrate nitrocefin, whose hydrolysis products absorb at 485 nm. Positive con-
trol was the CD200–CD200R1 interaction; control “prey” is an unrelated ectodomain, positive (+) rep-
resents total capture of all preys with an anti-prey antibody, and negative (−) represents a tag-only bait
control. (D) The interaction between IGF2R and GABBR2 can be completely inhibited by 10 mM soluble
M6P. The binding dependency onM6P was tested by adding serial dilutions of mannose, M6P, or buffer
alone. Data points in C and D are mean± SEM, n=3.
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ectodomain of GABBR2 interacts directly with IGF2R in a M6P-de-
pendent manner.
IGF2R is a trafficking receptor for GABBR2
Based on what is already known about the GABAB receptor com-
plex and IGF2R, we hypothesized that this interaction provided
a possible molecular mechanism to explain how GABAB receptors
are internalized from the cell surface to regulate their activity. To
test this, we first targeted IGF2R in Cas9-expressing HEK293 cells
and selected an IGF2R-deficient clonal line (Supplemental Fig.
S7A). To determine how the cell biology of the GABAB receptor
complex was altered in the absence of IGF2R, we transfected the
cells with cDNAs encoding both subunits of the GABAB receptor
and quantified the amount of GABAB receptor complex on the
surface of unpermeabilized cells (Fig. 5A). We observed that the
average amount of cell surface GABAB receptor complexwas signif-
icantly higher in the IGF2R-KO cell line (Fig. 5B; Supplemental Fig.
S7B,C), which is consistent with the model that GABAB receptor
complex internalization is promoted by IGF2R. It has also been
previously shown that GABAB receptor internalization depends
on clathrin-mediated internalization as treatment of cells with
hypertonic concentrations of sucrose or chlorpromazine, which
have been shown to inhibit the formation of clathrin-coated
pits, leads to a complete block of internalization of GABAB recep-
tors from the surface of HEK293 cells (Grampp et al. 2007). To
assess the influence of the clathrin-dependent pathway on the
internalization of the GABAB receptors, we used our cell-based
functional IGF2R–GABAB complex interaction assay. We observed
that upon treatment of cells with sucrose, the average amount of
cell surface GABAB receptor complex increased on a population
of parental HEK293 cells relative to a control demonstrating that
GABAB receptor trafficking depends on the clathrin pathway
(Fig. 5C). Additionally, to investigate the effect of the agonist
GABA on the interaction of the IGF2R–GABAB complex, we added
GABA to both the parental and IGF2R-deficient cells expressing
theGABAB receptor complex and quantified the IGF2R-dependent
internalization of the complex using our cell-based assay. We ob-
served that in the presence of GABA, there was no significant
difference in the ratio of cell surface GABAB receptor complex
between the parental and IGF2R-deficient cells, demonstrating
that GABA agonists have no effect on the IGF2R–GABAB receptor
complex interaction (Supplemental Fig. S8). These data demon-
strate that the IGF2R-mediated internalization of theGABAB recep-
tor complex is clathrin dependent, and provide evidence that
IGF2R is involved in the internalization of GABAB receptors
through direct interactions with the GABBR2 receptor subunit.
Discussion
Here we have shown how it is possible to use a cell-based, genome-
scale CRISPR-KO approach to identify genes encoding proteins
required for cellular recognition. This genetic approach provides
a valuable alternative to existing biochemical methods that must
account for the largely insoluble nature of membrane-embedded
receptors and the often highly transient nature of their extracellu-
lar interactions. This technique has advantages in that it not
only is able to reveal the receptor protein that directly interacts
with a presented ligand but can also identify other cell-intrinsic
gene products that are required for presenting the receptor at the
cell surface in an active conformation. In the experiments reported
here, this included essential chaperones, actin-interacting pro-
teins, vesicle trafficking adapters, enzymes required for specific
glycan biosynthesis, and transcription factors. Genes that were
repeatedly identified in different screens had known functional
roles in general “house-keeping” receptor biology, including those
involved in the secretory and general
glycosylation pathways. One important
advantage of this approach is that it
should be able to identify all gene prod-
ucts required for receptor interactions
without the need to make any prior as-
sumptions regarding the cell biology or
biochemical nature of the receptor. The
genetic nature of the approachmay be es-
pecially useful to identify interactions in-
volving membrane-embedded proteins
that are biochemically very challenging
to work with; for example, we show
here how this approach can confidently
identify the receptor for ERVW-1-RBD,
a protein that spans the membrane 12
times and is therefore difficult to solubi-
lize in an active conformation. We antic-
ipate that this single method will be
useful to explore the contribution of
other molecules such as lipids and may
reveal novel pathways for receptor traf-
ficking and biology.
We found that we could additional-
ly use this approach to investigate the
contribution to extracellular interactions
made by components of the cellular
glycocalyx such as GAGs. Many secreted
proteins are known to interact with
B CA
Figure 5. IGF2R traffics GABBR2 through a clathrin-dependent pathway. (A) Schematic of a flow cy-
tometry–based GABAB cell surface expression assay. Parental and IGF2R-KO HEK293 cells were cotrans-
fected with plasmids encoding both GABBR1 (R1) and GABBR2 (R2) full-length cDNAs and surface
expression of GABAB receptors quantified by antibody staining and FACS. A plasmid containing a GFP-
tagged CD200 cDNA was transfected in parallel and the number of transfected cells quantified by GFP
fluorescence. (B) The percentage of GABAB receptor–positive cells was significantly higher on the surface
of IGF2R-KO cells compared with the parental line (P<0.01 using Welch’s two sample t-test, n=3); con-
trol demonstrates both cell lines were transfected at comparable levels. Error bars, ± SD, n=3 (cells were
transfected in triplicate); a representative experiment of two independent experiments is shown. (C) The
clathrin-pathway inhibitor sucrose was added to parental and IGF2R-deficient HEK293 cells expressing
the GABAB receptor complex, and the cell surface receptor levels were quantified. The effect of sucrose
on the IGF2R–GABAB receptor complex interaction was determined by calculating the ratio of positively
stained cells on the parental cell line relative to the IGF2R-deficient cells and a buffer-only control. Sucrose
treatment led to a significant increase (P<0.05 using Welch’s two sample t-test) in cell surface GABAB
receptor complex staining on the parental cell line, almost to the same level as on the IGF2R-deficient
cells, demonstrating that that GABAB receptor trafficking depends on the clathrin pathway. The control
represents a transfection control to demonstrate parental and IGF2R-deficient cells were transfected with
equal efficiency. Bars, mean ± SD; n=3 (cells were transfected in triplicate).
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GAGs, especially HS, and similar cell-based genetic screens to iden-
tify pathogen receptors have shown that they also play important
roles in the interactions of bacteria (Rosmarin et al. 2012) and vi-
ruses (Marceau et al. 2016; Pillay et al. 2016) with host cells. The
interactions are largely electrostatic with the brush-like negatively
charged surface HS forming salt bridges with surface-exposed basic
residues and are generally thought to provide a suitable scaffold
to present ligands to host receptors in an appropriate manner by
regulating their orientation and oligomerization and by establish-
ing local concentration gradients (Yan and Lin 2009). The P. falcip-
arum RH5 protein is a typical example of a secreted protein that is
known to interact with both heparin-like molecules (Baum et al.
2009) and the BSG receptor (Crosnier et al. 2011), and we were
able to clearly identify both in a single experiment using our
approach. Further investigation showed that the contributions to
RH5 binding by BSG andHS, at least in this context, were indepen-
dent and could be experimentally separated. This finding enabled
us to rapidly establish whether sulfated GAGs played a role in the
binding of other ligands by testing binding on an SLC35B2-defi-
cient cell line or preincubating the ligand with heparin.
We demonstrated the utility of this technique by identifying
IGF2R as a binding partner for GABAB receptors. GABAB receptors
are expressed abundantly in almost all types of neurons and glia
throughout the central nervous system and mediate slow-acting
control of neuron excitability by inhibiting neurotransmitter re-
lease. This expression pattern overlaps with that of IGF2R, which
is also widely distributed throughout the nervous system with
particular enrichment in cortical areas, the hippocampus, and cer-
ebellum (Hawkes and Kar 2004). The regulation of the surface level
of GABAB receptors by endocytosis is an important mechanism to
attenuate signal strength and can be modelled in HEK293 cells,
where GABAB receptors are rapidly and constitutively internalized
by the clathrin-dependent pathway (Grampp et al. 2007) to early
endosomes. Our finding that IGF2R can directly interact with
the GABBR2 subunit of the GABAB receptor complex provides a
mechanism for the internalization because IGF2R is itself constitu-
tively endocytosed and trafficked to the endosome compartment
through clathrin-mediated uptake via “YSKV” motifs in its cyto-
plasmic region (Jadot et al. 1992). This is also consistent with
the regulatory role for the GABBR2 subunit in the uptake of the
GABAB receptor complex (Hannan et al. 2011) and the fact that
antibodies directed against the extracellular region, but not recep-
tor agonists, can inhibit GABAB receptor endocytosis (Grampp
et al. 2007). A similar role for IGF2R in down-regulating cell surface
receptor levels has been shown for CD26 in activated T cells
(Ikushima et al. 2000). This finding may now provide new oppor-
tunities to regulate GABAB receptor signaling to treat neurological
conditions such as epilepsy and depression.
In summary, we have applied a genome-scale, cell-based
genetic method based on CRISPR technology to identify genes
that mediate cellular recognition processes. We believe that this
approach, because it makes no prior assumptions regarding the
biochemical nature of the cell surface receptor, will make novel
and valuable insights into the molecular basis of cellular adhesion
and signaling.
Methods
Recombinant protein expression and quantitation
All proteins were expressed in HEK293 cells maintained in
FreeStyle media (Life Technologies) supplemented with 50 µg/mL
G418 and 0.1% Kolliphor P188 essentially as previously described
(Kerr and Wright 2012). For routine culture, 2.5 × 107 HEK293
cells were seeded in 500-mL Erlenmeyer culture flasks containing
100 mL culture media and cultured in a shaker set at 37°C, 5%
CO2, 70% humidity, and 125 rpm. To maintain a logarithmic
growth phase, cells were diluted into fresh media every 2–3 d
when the cell density reached ∼2×106/mL. HEK293 cells were
transiently transfected as previously described (Durocher et al.
2002); briefly, cells were prepared 48 h prior to transfection by
seeding at a density of 5 ×105 cells/mL, transfected, and incubated
for 5 d before supernatants were harvested by removing cells by
centrifugation at 3220g for 5 min and cell debris by filtering
through a 0.2-µm filter. For the production of biotinylated pro-
teins, the culture media was supplemented with 100 µM D-biotin
(Bushell et al. 2008) and cotransfected with a plasmid encoding
a secreted Escherichia coli BirA enzyme (Addgene plasmid no.
64395) as previously described (Kerr and Wright 2012). Superna-
tants containing pentameric recombinant proteins were stored at
4°C until further use, whereas the monomeric biotinylated his-
tagged proteins were enriched on Ni2+-NTA Sepharose beads
(Jena Biosciences) using gravity flow chromatography with poly-
propylene columns with a 50- to 100-µL bed volume (Qiagen).
The beads were washed once with wash buffer (20mMphosphate,
0.5 M NaCl, and 40 mM imidazole at pH 7.4) before the samples
were eluted with 300–500 µL of elution buffer (20 mMphosphate,
0.5 M NaCl, and 400 mM imidazole at pH 7.4). Eluted proteins
were separated by SDS-PAGE under reducing conditions and
visualized with InstantBlue (Expedeon) to confirm their size and
integrity following the manufacturer’s recommendations. A list
of the expression plasmids for human proteins used in this study
can be found in Supplemental Table S2.
Biotinylated protein expression levels were quantified by
ELISA as previously described (Kerr andWright 2012). Briefly, pro-
teins were captured on 96-well streptavidin-coated plates (NUNC)
for 1 h before adding 10 µg/mL primary antibody recognizing the
rat Cd4d3+4 tag (mouse anti-rat Cd4d3+4, clone OX68, Bio-Rad
[MCA1022R]) common to all recombinant proteins for another
hour. Plates were washed 3× in PBS/0.1% Tween-20 (PBST) before
adding 100 µL of an anti-mouse alkaline phosphatase conjugate
(Sigma, A3562) at 0.2 µg/mL. Plates were washed 3× PBST and 1×
PBS before adding 100 µL p-nitrophenyl phosphate (Sigma 104
alkaline phosphatase substrate) at 1 mg/mL in diethanolamine
buffer (10% diethanolamine [v/v], 0.5 mM MgCl2, 10 mM NaN3
at pH 9.8). Absorbance readings were taken 15–20 min post
substrate addition at 405 nm on a PHERAstar plus (BMG
Laboratories). Beta-lactamase–tagged proteins were quantified us-
ing nitrocefin hydrolysis as previously described (Bushell et al.
2008). The proteins were normalized to enzyme activity corre-
sponding to ∼1 nmol/min, which corresponds to complete hydro-
lysis of 14.5 nmol nitrocefin in ∼15 min.
Plate-based direct protein interaction assay
A biotinylated “bait” protein consisting of the entire ectodomain
of GABBR2 and controls were first immobilized in a well of a strep-
tavidin-coated 96-well microtiter plate (NUNC) at a concentration
that saturated the biotin binding capacity of the well and probed
for direct interactions with the entire ectodomain of IGF2R ex-
pressed as a beta-lactamase–tagged “prey.” The plate was washed
2× in PBST, after which normalized beta-lactamase–tagged
“prey” (IGF2R and controls) proteins were added to the wells
for 1 h. Following another wash step (2× with PBST and a final
wash with only PBS), 100 µL of 125 µg/mL nitrocefin was added,
and prey capture was quantified by measuring the absorbance of
nitrocefin hydrolysis products at 485 nm on a PHERAstar plus
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(BMG Laboratories). Biotinylated Cd4d3+4 tag alone was used as a
negative control bait, and a biotinylated anti-Cd4mAb (anti-prey)
used as a positive control as required.
Where soluble monosaccharides were used in blocking
experiments, prey proteins were first incubated with a range of
concentrations (10–0.04 mM) of M6P or mannose for 1 h, prior
to incubation with bait proteins. To remove N-linked glycans
from soluble recombinant GABBR2, 1500 U of PNGase F (New
England Biolabs) was added to 10 µg of GABBR2 and incubated
for a duration ranging from 1–16 h at 37°C.
Cell culture of human cell lines
NCI-SNU-1, HEL, and SK-N-SH cells were cultured in RPMI
1640 (Life Technologies) supplementedwith 10%heat-inactivated
(50°C for 20min) FBS, 1mM sodium pyruvate (Life Technologies),
10 mM D-glucose (Sigma), and penicillin–streptomycin at 37°C
with 5% CO2. HEK293 cells were cultured in FreeStyle media
(Life Technologies) supplemented with 1% heat-inactivated FBS
in shaker flasks in a shaking incubator set at 125 rpm, 37°C, 70%
humidity, and 5% CO2. To maintain a logarithmic growth phase,
NCI-SNU-1, HEL, and HEK-293 cells were diluted into fresh media
every 2–3 d once the cell density reached ∼1×106/mL. SK-N-SH
cells were grown in a monolayer, and the culture medium was
changed every 3 d. The cells were passaged once they reached
∼80% confluence. NCI-SNU-1 and SK-N-SH cells were obtained
from the Sanger Institute Cancer Cell Line Panel (https://cancer.
sanger.ac.uk/cell_lines). HEK293 cells were obtained from Dr. Yves
Durocher (Durocher et al. 2002). HEL cells were purchased from
Deutsche Sammlung von Mikroorganismen und Zellkulturen
(DSMZ). All cell lineswere tested and found to bemycoplasma free.
Cell binding assay with recombinant proteins and mAbs
Binding assay using biotinylated monomeric proteins
To increase binding avidity, biotinylated monomeric Cd4d3+4-
tagged proteins weremultimerized around streptavidin–phycoery-
thrin (PE). To ensure all biotin binding sites on the streptavidin
were occupied and to minimize the presence of excess monomer,
serial dilutions of biotinylated protein samples were titrated
against a fixed concentration of streptavidin–PE (100 µL of
0.1 µg/mL) for 20 min at room temperature before transferring
to a streptavidin-coated plate and assaying for the capture of any
excess biotinylated Cd4d3+4-tagged proteins using the OX68
ELISA. The minimal dilution at which all biotinylated Cd4d3+4-
tagged protein was captured was subsequently used to create tetra-
mers. A 10× tetramer staining solutionwas prepared using 4 µg/mL
streptavidin–PE and the appropriate biotinylated protein dilution
by incubating for 30 min at room temperature and then diluted to
1× and 100 µL added to 0.5–1×106 cells in an U-bottomed 96-well
microtiter plates and incubated for 1 h at room temperature.
Where the anti-BSG antibody was used in blocking experiments,
cells were first incubated with 10 µg/mL antibody (or isotype-
matched control) for 1 h prior to incubation with the RH5–strep-
tavidin–PE complex. Cells were washed once with wash buffer
(PBS with Ca2+/Mg2+ [HyClone, Sigma] supplemented with 1%
BSA) and analyzed by flow cytometry.
Binding assay using pentameric protein supernatants
The 3xFLAG and beta-lactamase–tagged pentameric proteins were
quantified directly from supernatants and normalized to∼1 nmol/
min using the beta-lactamase enzyme activity. Next, 100 µL of
diluted proteins was added to 0.5–1×106 cells in a U-bottomed
96-well microtiter plates for 1 h at room temperature. Following
a wash with wash buffer, 100 µL PE-conjugated anti-FLAG anti-
body (0.5 µg/mL, Abcam ab72469) was added to the samples
and incubated for 1 h. The cells were again washed once in wash
buffer and analyzed by flow cytometry.
Binding assay with mAbs
For antibody staining of cell surface proteins, 50 µL of 1 µg/mL
primary antibody was incubated with 1×106 cells in 96-well U
bottom plates. The cells were washed after 1 h of primary antibody
incubation, after which 100 µL of an appropriate secondary anti-
body, also conjugated to PE, was used at 0.1 µg/mL. For IGF2R
staining, anti-IGF2R mAB-clone-2G11 (Abcam, ab2733) was
used. For staining of GABAB receptors, anti-GABA B receptor 1 an-
tibody (Abcam, ab55051) was used.
Binding assay with transiently transfected cells
Human IGF2R was expressed on the surface of transfected cells
using an expression construct in which its cytoplasmic region
was replaced by eGFP, as previously described (Sollner and
Wright 2009). NCI-SNU-1 cells, which do not have detectable
levels of plasma membrane IGF2R expression, were transiently
transfected with either IGF2R-TM-eGFP or CD200R1-TM-eGFP as
a control and probed for binding interactions either with
GABBR2 ectodomain presented as a tetramer around streptavi-
din–PE or with an anti-IGF2R mAb (ab2733). Human GABAB re-
ceptor heterodimer was expressed on the surface of parental and
IGF2R-KO HEK293 cell lines by transiently cotransfecting both
GABBR1 and GABBR2 cDNA constructs using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s protocol.
CD200-TM-eGFP was transfected into the cells as a transfection
control. The surface level ofGABAB receptorswas analyzed 3 d after
transfection by surface-staining using a GABAB receptor 1 anti-
body (Abcam, ab55051).Where appropriate, the clathrin-pathway
inhibitor sucrose was added at 450 µM. All flow cytometry was
performed on a Becton-Dickinson LSRFortessa flow cytometer, col-
lecting between10,000 to 30,000 events; live cells were gated using
forward and side scatter. PE was excited at a wavelength of 561 nm
and emission detected using a 582/15 band pass filter; BFP was
excited at 405 nm and the emission detected using a 450/50
band pass filter; GFP was excited at 488 nm and the emission de-
tected using 530/30 band pass filter. Analysis was performed using
FlowJo software (Treestar).
Immunofluorescence of SK-N-SH cells
SK-N-SH cells grown as a monolayer in coverslips were fixed in 4%
formalin. Fixed cells were permeabilized in PBS/Triton X-100 0.1%
and blocked in PBS/2% BSA. Cells were stained with primary anti-
bodies: 1:400 anti-IGF2R (rabbit monoclonal, Abcam 124767)
and 1:250 anti-GABBR1 antibody (mouse monoclonal, Abcam
ab55051) overnight at 4°C. After three washes in the wash buffer
(PBS/2% BSA), the cells were incubated with secondary antibodies
(goat anti-mouse IgG [H+L] AlexaFluor 488 [Molecular Probes A-
11001], donkey anti-rabbit IgG [H+L] AlexaFluor 647 [Abcam
150075]) diluted 1:500 for 1 h at room temperature. The coverslips
were washed twice in wash buffer and three times in PBS and
mounted on a microscope glass in SlowFade with DAPI
(Molecular Probes) before images were captured with Leica SP5/
DM6000 confocal microscope.
Lentiviral vectors
TheHuman ImprovedGenome-Wide Knockout CRISPR Library v1
(Addgene no. 67989), lentiviral Cas9 reporter plasmids pKLV2-
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U6gRNA5(gGFP)-PGKBFP2AGFP-W (Addgene no. 67980) and
pKLV2-U6gRNA5(Empty)-PGKBFP2AGFP-W (Addgene no. 67979),
lentiviral vector expressing Cas9 fused with the blasticidin-resis-
tant gene at the C terminus pKLV2-EF1a-Cas9Bsd-W (Addgene
no. 68343), and lentiviral CRISPR gRNA expression vector
pKLV2-U6gRNA5(BbsI)-PGKpuro2ABFP-W (Addgene no. 67974)
were used in this study. All gene-specific gRNAs were cloned into
BbsI site of the gRNA expression vector as described previously
(Tzelepis et al. 2016).
Preparation of lentivirus and transductions
Lentivirus were prepared by transfecting HEK293-FT cells as previ-
ously described (Koike-Yusa et al. 2014). All Cas9-expressing hu-
man cell lines were selected following transduction of cells with
lentivirus prepared from the pKLV2-EF1a-Cas9Bsd-W plasmid
(Tzelepis et al. 2016). Polybrene (8 µg/mL) was added for the trans-
duction of NCI-SNU-1 and HEL cells. Cells were selected using
20 µg/mL blasticidin for the HEK293 and NCI-SNU-1 cell lines
and 10 µg/mL for HEL cells 2 d following transduction. We found
that polyclonal Cas9-expressing lines contained a variable fraction
(up to 30%) that were refractory to gene editing,which affected the
sensitivity of our screens. We therefore always established clonal
high Cas9 activity cell lines by sorting individual blasticidin-resis-
tant cells into wells of 96-well plates (MoFlo XDP), which were fur-
ther expanded and tested for Cas9 activity using the GFP-BFP
system (Tzelepis et al. 2016). In brief, cells were transduced with
lentivirus encoding GFP, BFP, and a gRNA targeting GFP (pKLV2-
U6gRNA5(gGFP)-PGKBFP2AGFP-W) or the same construct with
an “empty” gRNA (pKLV2-U6gRNA5(Empty)-PGKBFP2AGFP-W)
as a negative control. High-activity Cas9 stable cell lines were
selected by examining the ratio of BFP only to GFP-BFP double-
positive cells transduced by the two lentiviruses. These clonal
cell lines were expanded and further tested by targeting an endog-
enous gene encoding the BSG cell surface protein using lentivirus
prepared using a plasmid encoding puromycin, BFP, and a gRNA
targeting BSG [pKLV2-U6gRNA5(BbsI-gBSG)-PGKpuro2ABFP-W].
The surface expression of BSG was quantified by flow cytometry
using an anti-BSG mAb (MEM-M6/6, Abcam ab119114) 8 d post
transduction to validate high Cas9 efficiency.
Lentiviral transduction of HEK293 cells with genome-scale gRNA library
The CRISPR-KO library we used in this study contains 90,709
gRNAs targeting 18,009 human genes at a coverage of five gRNAs
per gene (Tzelepis et al. 2016). The backbone vector contains the
optimized gRNA scaffold, which can maximize genome editing
efficiency. A genome-scale “knock-out” library of HEK293-Cas9
cells was produced by transducing 3×107 cells such that ∼30%
of the total cell population were transduced to increase the chanc-
es that each cell just received a single gRNA. The transduced (BFP-
positive) cells were harvested 3 d after transduction using a cell
sorter (MoFlo XDP), and libraries containing at least 5 ×106 cells
were selected. The libraries were cultured in media containing
2 µg/mL puromycin to remove the contaminated nontransduced
cells, and at every passage, at least 10× the initial library (starting
cell number on day three) for each library was seeded into new cul-
ture flasks. Phenotyping screens for cell surface binding events
were carried out between 9 and 16 d post transduction.
Lentiviral transduction of NCI-SNU-1 and HEL cells with
genome-scale gRNA library
A spinoculation protocol was used to transduce HEL and NCI-
SNU-1 cell lines. Two milliliters of 5 ×106 cells/mL was aliquoted
in 8×15-mL Falcon tubes and mixed with lentivirus together
with 8 µg/mL polybrene and incubated at room temperature for
30 min followed by centrifugation for 100 min at 800g at 32°C.
The supernatant was removed, and the cells from each Falcon
tube were resuspended in 50 mL culture media. As with HEK293
cells, cells were sorted on day 3 post transduction to generate
control and sample libraries and were grown further in media sup-
plemented with 1 µg/mL puromycin.
Lentiviral transduction of human cells with individual gRNAs
For the validation of individual target genes, the correspond-
ing gRNAs from the CRISPR library (Supplemental Table S3)
were cloned into the BbsI site of pKLV2-U6gRNA5(BbsI)-
PGKpuro2ABFP-W, and lentivirus was produced as described be-
fore. Cells (1 × 106 cells/well in six-well plate) were transduced
with the lentivirus for at least 24 h. Polybrene (8 µg/mL)was added
during transduction of HEL and NCI-SNU-1 cell lines. Freshmedia
containing puromycin (2 µg/mL for HEK293 cells and 1 µg/mL for
all other cell lines) was added to the cells after transduction and
cultured for a further 8 d before use in binding assays.
Cell surface phenotyping, selection, and amplification
of selected gRNAs
To identify the genes required for cell surface recognition, the
binding of the soluble ligand (mAb or recombinant protein) of
interest was first quantified by flow cytometry to a small panel of
cell lines, and the cell line exhibiting the highest level of binding
was typically selected for genome-wide screening. Genome-scale
knock-out libraries were phenotyped by cell surface staining using
flow cytometry between 9 and 16 d post transduction. Themutant
library was divided into two parts: At least 5 × 107 cells from
the mutant library were collected as “control” population for
later analysis, whereas 5 ×107–15×107 cells from the library were
stained with appropriate reagent (recombinant protein or anti-
body) using the binding assay protocol as described above with
minor modifications: Cells (5 × 106 cells/mL) were stained in 15-
mL Falcon tubes with gentle rotation (6 rpm), the stained cells
were then analyzed using an XDP flow sorter, and the BFP+/PE−
cells were collected. The percentage of the total library population
that was collected in each screen varied between 0.2% and 2.3%
and are listed in Supplemental Table S4. We observed that strin-
gent sorting thresholds resulted in the identification of few genes
that had strong effects on binding loss, and increasing this thresh-
old enabled the identification of additional genes that presumably
had weaker effect sizes on the day of screening. We determined
that collecting between 300,000 and 500,000 cells at a 0.5%–1%
stringency threshold was generally an appropriate parameter that
permitted the identification of genes with weaker effect sizes. All
genetic screens except those performed using anti-CD59 mAb
andTIGIT recombinant protein in this studywere carried out once.
Amplification of gRNAs, sequencing, and enrichment analysis
Genomic DNA extraction, PCR enrichment, and Illumina se-
quencing of gRNAs from both control and sorted samples were
carried out as described previously (Koike-Yusa et al. 2014), except
in sorted samples where the sorted cell number was less than
100,000. In that case, a cell lysate protocol was used to isolate
gRNAs prior to PCR enrichment. Cell lysates were prepared from
sorted cells by first aliquoting cells in a 96-well PCR plate
(10,000 cells/well) and boiling the samples with 25 µL water
for 10 min at 95°C. Next, 5 µL of 2 mg/mL freshly diluted
Proteinase K was added to each sample and incubated for 1 h at
56°C and thenheated for 10min at 95°C to inactivate the protease.
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The gRNAs were then amplified using 10-µL cell lysates per PCR
reaction.
For all samples, 19-bp single-end sequencing was performed
using a custom sequencing primer 5′-TCTTCCGATCTCTTGTGG
AAAGGACGAAACACCG-3′. The read count for each gRNA and
gene level enrichment analysis was carried out using the
MAGeCK statistical package (version 0.5.5) (Li et al. 2014) by com-
paring the read counts from the sorted populationwith those from
the control population. Pathway analysis was also carried out us-
ing MAGeCK software with default settings with KEGG annotated
pathways. All further analysis was carried out using R (RCore Team
2017). For all the target receptors identified, the ranks of the indi-
vidual gRNAs targeting the related gene are listed in Supplemental
Table S5.
Quantifying gRNA representation in mutant cell libraries
to ensure maintenance of library complexity
Weobserved that it was necessary to culture the cells for between 9
and 16 d after transduction to allow sufficient time for gene target-
ing and consequent loss of the encoded protein. During this time,
gRNAs can be lost from the library for biological reasons (e.g., the
gRNA targets a gene essential for cell survival) or for technical
reasons (such as the need to passage the library because of cell
growth that may create population restriction points reducing
gRNA library representation). To ensure that gRNA representation
is maintained using our cellular KO library preparation protocol,
we quantified the gRNA abundance in at least 5 ×107 cells on dif-
ferent days after transduction from two independent NCI-SNU-1-
Cas9 libraries and one library of both HEK293-Cas9 and HEL-Cas9
cells. We observed that gRNA abundances were highly correlated
between the biological replicates of NCI-SNU-1-Cas9 libraries,
and similarly high correlations were observed among the three dif-
ferent cell line libraries at equivalent time points, demonstrating
that the procedure we used to make genome-scale mutant libraries
was reproducible (Supplemental Fig. S9). The correlation between
the different mutant cell line libraries and the original plasmid
population was lower, and so the most appropriate control for
gRNA enrichment analysis was the cell line on that day rather
than the population of gRNAs in the original plasmid population.
To further compare the gRNA abundances, the number of
sequence reads for each gRNA between the original plasmid pool
and each cell library was quantified. In the plasmid library, while
a small fraction of gRNAs was under- or overrepresented, >82%
of the gRNAs were uniformly distributed, with only an eightfold
difference in abundance between the 10th and 90th percentiles.
The cell-based mutant libraries created from this plasmid library
also showed a uniform coverage, although a small drop in the over-
all representation of the gRNA library was observed in all cell lines
as expected, and this decrease was more pronounced when com-
paring days 9–16 post transduction. It is likely that these depleted
gRNAs target genes that are essential for cell growth in culture.
To establish this, we performed a gene-level negative selection
enrichment analysis to identify genes that were depleted in the
mutant library compared with the plasmid library in all 3 d in
the NCI-SNU-1 and HEK293 cell lines and on day 14 for HEL cells.
As a quality control, we initially analyzed genes required for ribo-
some biosynthesis (annotations fromKEGG-Ribosome), which are
known to be essential and are often robustly identified in similar
negative selection screens (Wang et al. 2014; Hart et al. 2015).
Reassuringly, themajority of gRNAs targeting genes required for ri-
bosome biosynthesis were among the most significantly depleted
(FDR<10%) across all 3 d in all three cell lines (Supplemental Fig.
S10). Next, we attempted to identify which pathways were defined
by the genes targeted by the enriched gRNAs using KEGG annotat-
ed pathways (Kanehisa et al. 2017).We observed that the pathways
identified were in biological processes described as being essential,
including those required for the spliceosome, cell cycle, purine
andpyrimidine biosynthesis, and bothDNA andRNApolymerases
(Supplemental Data S4). These results provided further confidence
that the cellular mutant libraries generated using our protocol re-
tained their gRNA complexity and could be used for genome-scale
screening.
Data access
All reads from the genome-wide screening experiments in this
study have been submitted to the European Nucleotide Archive
(http://www.ebi.ac.uk/ena) under accession number ERP104831.
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